Literature DB >> 16447284

Temporal pattern of C1q deposition after transient focal cerebral ischemia.

William J Mack1, Michael E Sughrue, Andrew F Ducruet, J Mocco, Sergey A Sosunov, Benjamin G Hassid, Joshua Z Silverberg, Vadim S Ten, David J Pinsky, E Sander Connolly.   

Abstract

Recent studies have focused on elucidating the contribution of individual complement proteins to post-ischemic cellular injury. As the timing of complement activation and deposition after cerebral ischemia is not well understood, our study investigates the temporal pattern of C1q accumulation after experimental murine stroke. Brains were harvested from mice subjected to transient focal cerebral ischemia at 3, 6, 12, and 24 hr post reperfusion. Western blotting and light microscopy were employed to determine the temporal course of C1q protein accumulation and correlate this sequence with infarct evolution observed with TTC staining. Confocal microscopy was utilized to further characterize the cellular localization and characteristics of C1q deposition. Western Blot analysis showed that C1q protein begins to accumulate in the ischemic hemisphere between 3 and 6 hr post-ischemia. Light microscopy confirmed these findings, showing concurrent C1q protein staining of neurons. Confocal microscopy demonstrated co-localization of C1q protein with neuronal cell bodies as well as necrotic cellular debris. These experiments demonstrate the accumulation of C1q protein on neurons during the period of greatest infarct evolution. This data provides information regarding the optimal time window during which a potentially neuroprotective anti-C1q strategy is most likely to achieve therapeutic success.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16447284     DOI: 10.1002/jnr.20775

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

Review 1.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

2.  The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.

Authors:  Andrew Elvington; Carl Atkinson; Hong Zhu; Jin Yu; Kazue Takahashi; Gregory L Stahl; Mark S Kindy; Stephen Tomlinson
Journal:  J Immunol       Date:  2012-10-01       Impact factor: 5.422

3.  Complement component c1q mediates mitochondria-driven oxidative stress in neonatal hypoxic-ischemic brain injury.

Authors:  Vadim S Ten; Jun Yao; Veniamin Ratner; Sergey Sosunov; Deborah A Fraser; Marina Botto; Baalasubramanian Sivasankar; B Paul Morgan; Samuel Silverstein; Raymond Stark; Richard Polin; Susan J Vannucci; David Pinsky; Anatoly A Starkov
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

4.  Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.

Authors:  Sung-Chun Tang; Justin D Lathia; Pradeep K Selvaraj; Dong-Gyu Jo; Mohamed R Mughal; Aiwu Cheng; Dominic A Siler; William R Markesbery; Thiruma V Arumugam; Mark P Mattson
Journal:  Exp Neurol       Date:  2008-05-29       Impact factor: 5.330

5.  Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.

Authors:  Liudmila Kulik; Sherry D Fleming; Chantal Moratz; Jason W Reuter; Aleksey Novikov; Kuan Chen; Kathy A Andrews; Adam Markaryan; Richard J Quigg; Gregg J Silverman; George C Tsokos; V Michael Holers
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

6.  Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits.

Authors:  Sung-Chun Tang; Thiruma V Arumugam; Xiangru Xu; Aiwu Cheng; Mohamed R Mughal; Dong Gyu Jo; Justin D Lathia; Dominic A Siler; Srinivasulu Chigurupati; Xin Ouyang; Tim Magnus; Simonetta Camandola; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-10       Impact factor: 11.205

7.  Inhibition of Complement Drives Increase in Early Growth Response Proteins and Neuroprotection Mediated by Salidroside After Cerebral Ischemia.

Authors:  Wenfang Lai; XiuLi Xie; Xiaoqin Zhang; Yingzheng Wang; Kedan Chu; John Brown; Lidian Chen; Guizhu Hong
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 8.  Platelet mediated complement activation.

Authors:  Ellinor I B Peerschke; Wei Yin; Berhane Ghebrehiwet
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 9.  Aberrant Complement System Activation in Neurological Disorders.

Authors:  Karolina Ziabska; Malgorzata Ziemka-Nalecz; Paulina Pawelec; Joanna Sypecka; Teresa Zalewska
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

10.  Proteomic Characterization of the Dynamics of Ischemic Stroke in Mice.

Authors:  Rong-Fang Gu; Terry Fang; Ashley Nelson; Stefka Gyoneva; Benbo Gao; Joe Hedde; Kate Henry; Emily Peterson; Linda C Burkly; Ru Wei
Journal:  J Proteome Res       Date:  2021-06-04       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.